Lightspeed Venture Partners
A Scientist at a drug discovery company works on cell-based assays and translational biology efforts in a fast-paced start-up environment.
Headquarters
Menlo Park, California, United States
Company Size
51-200 employees
Founded
2000
Lightspeed Venture Partners is a multi-stage venture capital firm focused on accelerating disruptive innovations and trends. It backs founders from seed through growth, providing capital, strategic guidance, and operational support to scale high-impact companies across consumer and enterprise technology and adjacent sectors. With a global footprint, Lightspeed partners for the long term to help companies grow into category leaders.
Antares Therapeutics Launches with $177 Million to Develop First-in-Class Precision Medicines for Cancer and Other Serious Diseases
Jun 10, 2025
Scorpion spinout raises $177M to advance preclinical assets after 2 clinical programs sold to Pierre Fabre
Jun 10, 2025
Scorpion, fresh off Lilly deal, spins out startup Antares
Jun 10, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Lightspeed Venture Partners.
76% above the average for this role
Scorpion spin-off Antares launches with $177 million
Jun 16, 2025
Associate Scientist II/Senior Associate Scientist Biology
Iambic Therapeutics
B-Cell Biologist
Monte Rosa Therapeutics, Inc
Pharma Discovery Molecular Biologist
Cogent Scientific
Research Associate, Discovery Biology
Assembly Bio
Research Associate, Biology
Olema Oncology
Research Associate in Ophthalmology
Roche